Overview
Announcements

Ordinary Adjustment | Morgan Stanley U.S. Biotechnology Index | Effective Date 1st May 2025

Morgan Stanley U.S. Biotechnology Index:

In the ordinary adjustment, the following composition will be implemented effective open 1st May 2025:

ACADIA PHARMACEUTICALS INC
ADMA BIOLOGICS INC
AGIOS PHARMACEUTICALS INC
AKERO THERAPEUTICS INC
ALKERMES PLC
ALNYLAM PHARMACEUTICALS INC
AMGEN INC
AMICUS THERAPEUTICS INC
AMNEAL PHARMACEUTICALS INC
ANI PHARMACEUTICALS INC
APOGEE THERAPEUTICS ORD
ARCELLX INC
ARCUTIS BIOTHERAPEUTICS INC
ARDELYX INC
ARROWHEAD PHARMACEUTICALS INC
AVIDITY BIOSCIENCES INC
AXSOME THERAPEUTICS INC
BEAM THERAPEUTICS INC
BIOCRYST PHARMACEUTICALS INC
BIOGEN INC
BIOMARIN PHARMACEUTICAL INC
BLUEPRINT MEDICINES CORP
BRIDGEBIO PHARMA INC
CATALYST PHARMACEUTICALS INC
CG ONCOLOGY INC
CORCEPT THERAPEUTICS INC
CRINETICS PHARMACEUTICALS INC
CYTOKINETICS INC
DENALI THERAPEUTICS INC
DISC MEDICINE INC
DYNAVAX TECHNOLOGIES CORP
EDGEWISE THERAPEUTICS INC
EXELIXIS INC
GILEAD SCIENCES INC
HALOZYME THERAPEUTICS INC
HARMONY BIOSCIENCES HOLDINGS INC
IDEAYA BIOSCIENCES INC
IMMUNOVANT INC
INCYTE CORP
INNOVIVA INC
INSMED INC
IONIS PHARMACEUTICALS INC
JANUX THERAPEUTICS INC
KRYSTAL BIOTECH INC
KYMERA THERAPEUTICS INC
MADRIGAL PHARMACEUTICALS INC
MIRUM PHARMACEUTICALS INC
MODERNA INC
MOONLAKE IMMUNOTHERAPEUTICS
NEUROCRINE BIOSCIENCES INC
NEW BIOHAVEN
Nuvalent Inc
ORGANON & CO
PACIRA BIOSCIENCES INC
PERRIGO CO PLC
PRESTIGE CONSUMER HEALTHCARE INC
PROTAGONIST THERAPEUTICS INC
PTC THERAPEUTICS INC
REGENERON PHARMACEUTICALS
REVOLUTION MEDICINES INC
RHYTHM PHARMACEUTICALS INC
ROYALTY PHARMA PLC- CL A
SAREPTA THERAPEUTICS INC
SCHOLAR ROCK HOLDING CORP
SOLENO THERAPEUTICS INC
SUMMIT THERAPEUTICS PLC
SUPERNUS PHARMACEUTICALS INC
SYNDAX PHARMACEUTICALS INC
TARSUS PHARMACEUTICALS INC
TG THERAPEUTICS INC
TRAVERE THERAPEUTICS INC
ULTRAGENYX PHARMACEUTICAL INC
UNITED THERAPEUTICS CORP
VAXCYTE INC
VERA THERAPEUTICS INC
VERTEX PHARMACEUTICALS INC
VIATRIS INC
VIKING THERAPEUTICS INC